Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Chen, Chao Yin ^a   Matt, Lucas ^a   Hell, Johannes Wilhelm ^a   Rogawski, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PERAMPANEL; PYRIDONE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESPONSE; EMBRYO; FEMALE; HIPPOCAMPAL NEURONAL CULTURE; IC50; IN VITRO STUDY; NONHUMAN; PROTEIN TRANSPORT; RAT; RECEPTOR DOWN REGULATION; STEADY STATE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ELECTROPHYSIOLOGY; HIPPOCAMPUS; KINETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; ELECTROPHYSIOLOGICAL PROCESSES; FEMALE; HIPPOCAMPUS; KAINIC ACID; KINETICS; NEURONS; PREGNANCY; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 84907220225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108021     Document Type: Article

References (25)

1. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, et al. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62: 405-496. DOI: 10.1124/pr.109.002451.
2. Löscher W, Rogawski MA (2002) Epilepsy. In: Lodge D, Danysz W, Parsons CG, editors. Ionotropic glutamate receptors as therapeutic targets. Johnson City, TN: F.P. Graham Publishing Co. 91-132.
3. Rogawski MA (2013) AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl 2013;(197): 9-18. DOI: 10.1111/ane.12099.
4. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T (1990) 2,3- Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571-574. DOI: 10.1126/science.2154034.
5. Hogner A, Greenwood JR, Liljefors T, Lunn ML, Egebjerg J, et al. (2003) Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX. J Med Chem 46: 214-21. DOI: 10.1021/jm020989v.
6. Donevan SD, Rogawski MA (1993) GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10: 51-59. DOI: 10.1016/0896-6273(93)90241-I.
7. Sólyom S, Tarnawa I (2002) Non-competitive AMPA antagonists of 2,3- benzodiazepine type. Curr Pharm Des 8: 913-939. DOI: 10.2174/ 1381612024607081.
8. Ritz M, Wang C, Micale N, Ettari R, Niu L (2011) Mechanism of inhibition of the GluA2 AMPA receptor channel opening: the role of 4-methyl versus 4- carbonyl group on the diazepine ring of 2,3-benzodiazepine derivatives. ACS Chem Neurosci 2: 506-513. DOI: 10.1021/cn200033j.
9. Wang C, Han Y, Wu A, Sólyom S, Niu L (2013) Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci 5: 138-147. DOI: 10.1021/cn400193u.
10. Lazzaro JT, Paternain AV, Lerma J, Chenard BL, Ewing FE, et al. (2002) Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist. Neuropharmacology 42: 143-153. DOI: 10.1016/S0028- 3908(01)00170-8.
11. Balannik V, Menniti FS, Paternain AV, Lerma J, Stern-Bach Y (2005) Molecular mechanism of AMPA receptor noncompetitive antagonism. Neuron 48: 279-288. DOI: 10.1016/j.neuron.2005.09.024.
12. Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, et al. (2103) Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia 54: 1481-1489. DOI: 10.1111/epi.12212.
13. Krauss GL (2013) Perampanel: a selective AMPA antagonist for treating seizures. Epilepsy Curr 13: 269-272. DOI: 10.5698/1535-7597-13.6.269.
14. Hibi S, Ueno K, Nagato S, Kawano K, Ito K, et al. (2012) Discovery of 2-(2- oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive a-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem 55: 10584-11600. DOI: 10.1021/jm301268u.
15. Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, et al. (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52: 1331- 1140. DOI: 10.1111/j.1528-1167.2011.03109.x.
16. Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, et al. (2012) A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptormediated synaptic transmission in the hippocampus. Neurochem Int 61: 517-522. DOI: 10.1016/j.neuint.2012.02.035.
17. Tokuhara N, Hatakeyama S, Amino H, Hanada T, Nishizawa Y (2008) Pharmacological profile of perampanel: a novel, non-competitive selective AMPA receptor antagonist. J Neurol 255: 175 (Abstract P706). DOI: 10.1007/ s00415-008-2001-5.
18. Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, et al. (2008) NS21: redefined and modified supplement B27 for neuronal cultures. J Neurosci Methods 171: 239-247. DOI: 10.1016/j.jneumeth.2008.03.013.
19. Lerma J, Paternain AV, Naranjo JR, Mellström B (1993) Functional kainateselective glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci USA 90: 11688-11692.
20. Patneau DK, Vyklicky L Jr, Mayer ML (1993) Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J Neurosci 13: 3496-3509.
21. Paternain AV, Morales M, Lerma J (1995) Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14: 185-189. DOI:10.1016/0896-6273(95)90253-8.
22. Stern-Bach Y, Russo S, Neuman M, Rosenmund C (1998) A point mutation in the glutamate binding site blocks desensitization of AMPA receptors. Neuron 21: 907-918. DOI: 10.1016/S0896-6273(00)80605-4.
23. Armstrong N, Gouaux E (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28: 165-181. DOI: 10.1016/S0896-6273(00)00094-5.
24. Parsons CG, Gruner R, Rozental J (1994) Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6- nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl- 7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Neuropharmacology 33: 589-604. DOI: 10.1016/0028-3908(94)90163-5.
25. Donevan SD, Rogawski MA (1998) Allosteric regulation of a-amino-3-hydroxy- 5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Neuroscience 87: 615-629. DOI: 10.1016/S0306-4522(98)00109-2.